VERBIO Vereinigte BioEnergie AG Logo

VERBIO Vereinigte BioEnergie AG

VBK.DE

(3.0)
Stock Price

12,35 EUR

1.45% ROA

2.15% ROE

54.36x PER

Market Cap.

1.086.940.456,00 EUR

20.98% DER

1.17% Yield

1.2% NPM

VERBIO Vereinigte BioEnergie AG Stock Analysis

VERBIO Vereinigte BioEnergie AG Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

VERBIO Vereinigte BioEnergie AG Fundamental Stock Analysis
# Analysis Rating
1 ROA

The stock's ability to make a lot of money from its assets shows that it is very profitable, making it a good choice for people who want to invest and make a lot of money.

2 DER

The stock has a minimal amount of debt (21%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Revenue Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

4 Assets Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

5 ROE

ROE in an average range (14.81%) suggests satisfactory profitability and decent utilization of shareholders' equity.

6 PBV

The stock's PBV ratio (2.41x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

7 Dividend

The company's track record of consistently paying dividends in the last three years highlights its dedication to providing investors with regular income.

8 Buffet Intrinsic Value

The company's stock shows potential as it is undervalued (827) according to Warren Buffett's formula, indicating that its intrinsic value exceeds the market price.

9 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

10 Graham Number

The Graham number calculation reveals that this company's stock price is potentially inflated, implying that it may not be a desirable investment option.

11 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

VERBIO Vereinigte BioEnergie AG Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

VERBIO Vereinigte BioEnergie AG Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Buy

VERBIO Vereinigte BioEnergie AG Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

VERBIO Vereinigte BioEnergie AG Revenue
Year Revenue Growth
2007 0
2008 668.459.000 100%
2009 503.662.000 -32.72%
2010 522.077.000 3.53%
2011 0 0%
2012 705.231.000 100%
2013 733.766.000 3.89%
2014 618.492.000 -18.64%
2015 654.329.000 5.48%
2016 726.442.000 9.93%
2017 685.898.000 -5.91%
2018 779.317.000 11.99%
2019 872.398.000 10.67%
2020 1.026.035.000 14.97%
2021 1.812.477.000 43.39%
2022 1.968.281.000 7.92%
2023 1.359.640.000 -44.76%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

VERBIO Vereinigte BioEnergie AG Research and Development Expenses
Year Research and Development Expenses Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 828.000 100%
2013 858.000 3.5%
2014 796.000 -7.79%
2015 1.098.000 27.5%
2016 1.152.000 4.69%
2017 1.406.000 18.07%
2018 2.029.000 30.7%
2019 5.444.000 62.73%
2020 6.227.000 12.57%
2021 6.483.000 3.95%
2022 4.701.000 -37.91%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

VERBIO Vereinigte BioEnergie AG General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 0
2008 17.119.000 100%
2009 0 0%
2010 0 0%
2011 0 0%
2012 7.625.000 100%
2013 2.356.000 -223.64%
2014 1.649.000 -42.87%
2015 1.498.000 -10.08%
2016 1.611.000 7.01%
2017 1.577.000 -2.16%
2018 3.619.000 56.42%
2019 4.849.000 25.37%
2020 5.182.000 6.43%
2021 10.395.000 50.15%
2022 12.272.000 15.29%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

VERBIO Vereinigte BioEnergie AG EBITDA
Year EBITDA Growth
2007 394.594.000
2008 -5.711.000 7009.37%
2009 12.256.000 146.6%
2010 108.569.000 88.71%
2011 0 0%
2012 8.384.000 100%
2013 34.684.000 75.83%
2014 47.844.000 27.51%
2015 70.382.000 32.02%
2016 92.994.000 24.32%
2017 46.241.000 -101.11%
2018 97.781.000 52.71%
2019 124.334.000 21.36%
2020 183.241.000 32.15%
2021 512.944.000 64.28%
2022 237.303.000 -116.16%
2023 103.228.000 -129.88%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

VERBIO Vereinigte BioEnergie AG Gross Profit
Year Gross Profit Growth
2007 370.532.000
2008 64.251.000 -476.69%
2009 41.482.000 -54.89%
2010 57.991.000 28.47%
2011 0 0%
2012 46.208.000 100%
2013 67.075.000 31.11%
2014 83.515.000 19.69%
2015 106.598.000 21.65%
2016 134.436.000 20.71%
2017 84.450.000 -59.19%
2018 149.215.000 43.4%
2019 184.372.000 19.07%
2020 257.740.000 28.47%
2021 610.890.000 57.81%
2022 381.913.000 -59.96%
2023 319.728.000 -19.45%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

VERBIO Vereinigte BioEnergie AG Net Profit
Year Net Profit Growth
2007 0
2008 9.075.000 100%
2009 -7.263.000 224.95%
2010 7.987.000 190.94%
2011 0 0%
2012 -152.513.000 100%
2013 5.262.000 2998.38%
2014 26.780.000 80.35%
2015 48.746.000 45.06%
2016 51.499.000 5.35%
2017 14.923.000 -245.1%
2018 52.968.000 71.83%
2019 63.381.000 16.43%
2020 93.203.000 32%
2021 315.625.000 70.47%
2022 132.024.000 -139.07%
2023 34.064.000 -287.58%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

VERBIO Vereinigte BioEnergie AG Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 -2 100%
2013 0 0%
2014 0 0%
2015 1 0%
2016 1 0%
2017 0 0%
2018 1 0%
2019 1 100%
2020 1 0%
2021 5 75%
2022 2 -100%
2023 1 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

VERBIO Vereinigte BioEnergie AG Free Cashflow
Year Free Cashflow Growth
2007 -84.171.000
2008 59.299.000 241.94%
2009 -58.640.000 201.12%
2010 -9.762.000 -500.7%
2011 -36.275.000 73.09%
2012 -55.864.000 35.07%
2013 68.897.000 181.08%
2014 32.961.000 -109.03%
2015 63.138.000 47.8%
2016 56.470.000 -11.81%
2017 -14.280.000 495.45%
2018 -18.945.000 24.62%
2019 3.577.000 629.63%
2020 49.904.000 92.83%
2021 210.154.000 76.25%
2022 -177.121.000 218.65%
2023 13.307.000 1431.04%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

VERBIO Vereinigte BioEnergie AG Operating Cashflow
Year Operating Cashflow Growth
2007 -84.171.000
2008 68.385.000 223.08%
2009 -32.708.000 309.08%
2010 25.327.000 229.14%
2011 -16.144.000 256.88%
2012 -19.511.000 17.26%
2013 76.407.000 125.54%
2014 46.612.000 -63.92%
2015 76.286.000 38.9%
2016 75.020.000 -1.69%
2017 11.081.000 -577.01%
2018 44.327.000 75%
2019 71.678.000 38.16%
2020 117.183.000 38.83%
2021 325.031.000 63.95%
2022 26.094.000 -1145.62%
2023 47.875.000 45.5%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

VERBIO Vereinigte BioEnergie AG Capital Expenditure
Year Capital Expenditure Growth
2007 0
2008 9.086.000 100%
2009 25.932.000 64.96%
2010 35.089.000 26.1%
2011 20.131.000 -74.3%
2012 36.353.000 44.62%
2013 7.510.000 -384.06%
2014 13.651.000 44.99%
2015 13.148.000 -3.83%
2016 18.550.000 29.12%
2017 25.361.000 26.86%
2018 63.272.000 59.92%
2019 68.101.000 7.09%
2020 67.279.000 -1.22%
2021 114.877.000 41.43%
2022 203.215.000 43.47%
2023 34.568.000 -487.87%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

VERBIO Vereinigte BioEnergie AG Equity
Year Equity Growth
2007 318.777.000
2008 325.049.000 1.93%
2009 311.094.000 -4.49%
2010 332.495.000 6.44%
2011 331.496.000 -0.3%
2012 178.308.000 -85.91%
2013 183.544.000 2.85%
2014 209.664.000 12.46%
2015 254.325.000 17.56%
2016 296.391.000 14.19%
2017 300.217.000 1.27%
2018 338.917.000 11.42%
2019 390.823.000 13.28%
2020 509.872.000 23.35%
2021 818.455.000 37.7%
2022 911.827.000 10.24%
2023 928.216.000 1.77%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

VERBIO Vereinigte BioEnergie AG Assets
Year Assets Growth
2007 543.248.000
2008 491.075.000 -10.62%
2009 485.558.000 -1.14%
2010 608.404.000 20.19%
2011 658.874.000 7.66%
2012 410.413.000 -60.54%
2013 302.658.000 -35.6%
2014 296.343.000 -2.13%
2015 323.013.000 8.26%
2016 373.079.000 13.42%
2017 365.989.000 -1.94%
2018 424.945.000 13.87%
2019 529.200.000 19.7%
2020 678.621.000 22.02%
2021 1.128.619.000 39.87%
2022 1.297.187.000 12.99%
2023 1.377.755.000 5.85%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

VERBIO Vereinigte BioEnergie AG Liabilities
Year Liabilities Growth
2007 224.471.000
2008 166.026.000 -35.2%
2009 174.464.000 4.84%
2010 275.909.000 36.77%
2011 327.378.000 15.72%
2012 232.105.000 -41.05%
2013 119.114.000 -94.86%
2014 86.679.000 -37.42%
2015 68.688.000 -26.19%
2016 76.688.000 10.43%
2017 65.772.000 -16.6%
2018 86.028.000 23.55%
2019 138.377.000 37.83%
2020 168.749.000 18%
2021 310.164.000 45.59%
2022 385.360.000 19.51%
2023 449.539.000 14.28%

VERBIO Vereinigte BioEnergie AG Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
26.1
Net Income per Share
0.31
Price to Earning Ratio
54.36x
Price To Sales Ratio
0.66x
POCF Ratio
9.29
PFCF Ratio
-19.99
Price to Book Ratio
1.17
EV to Sales
0.7
EV Over EBITDA
9.8
EV to Operating CashFlow
9.92
EV to FreeCashFlow
-21.29
Earnings Yield
0.02
FreeCashFlow Yield
-0.05
Market Cap
1,09 Bil.
Enterprise Value
1,16 Bil.
Graham Number
10.15
Graham NetNet
-0.8

Income Statement Metrics

Net Income per Share
0.31
Income Quality
5.87
ROE
0.02
Return On Assets
0.01
Return On Capital Employed
0.06
Net Income per EBT
0.33
EBT Per Ebit
0.8
Ebit per Revenue
0.05
Effective Tax Rate
0.67

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.17
Operating Profit Margin
0.05
Pretax Profit Margin
0.04
Net Profit Margin
0.01

Dividends

Dividend Yield
0.01
Dividend Yield %
1.17
Payout Ratio
0.64
Dividend Per Share
0.2

Operating Metrics

Operating Cashflow per Share
1.84
Free CashFlow per Share
-0.86
Capex to Operating CashFlow
1.47
Capex to Revenue
0.1
Capex to Depreciation
3.29
Return on Invested Capital
0.02
Return on Tangible Assets
0.01
Days Sales Outstanding
43.84
Days Payables Outstanding
33.62
Days of Inventory on Hand
65.13
Receivables Turnover
8.33
Payables Turnover
10.86
Inventory Turnover
5.6
Capex per Share
2.69

Balance Sheet

Cash per Share
1,99
Book Value per Share
14,61
Tangible Book Value per Share
14.59
Shareholders Equity per Share
14.57
Interest Debt per Share
3.22
Debt to Equity
0.21
Debt to Assets
0.14
Net Debt to EBITDA
0.6
Current Ratio
2.71
Tangible Asset Value
0,93 Bil.
Net Current Asset Value
0,13 Bil.
Invested Capital
1126013000
Working Capital
0,37 Bil.
Intangibles to Total Assets
0
Average Receivables
0,16 Bil.
Average Payables
0,12 Bil.
Average Inventory
252281499.5
Debt to Market Cap
0.18

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

VERBIO Vereinigte BioEnergie AG Dividends
Year Dividends Growth
2016 0
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

VERBIO Vereinigte BioEnergie AG Profile

About VERBIO Vereinigte BioEnergie AG

VERBIO Vereinigte BioEnergie AG produces and supplies biofuels in Germany and rest of Europe. The company's products include biodiesel, bioethanol, biomethane, biosterol, bioglycerin, and liquid fertilizers. The company offers its products to oil corporations, oil traders, independent filling stations, haulage companies, public utilities, and vehicle fleets. VERBIO Vereinigte BioEnergie AG was founded in 2006 and is headquartered in Leipzig, Germany.

CEO
Mr. Claus Sauter
Employee
1.372
Address
Ritterstrasse 23
Leipzig, 04109

VERBIO Vereinigte BioEnergie AG Executives & BODs

VERBIO Vereinigte BioEnergie AG Executives & BODs
# Name Age
1 Dr. Oliver Ludtke
Deputy Chief Executive Officer, Chief Technology Officer & Vice-Chairman of the Management Board
70
2 Mr. Bernd Sauter
Executive Board Member for Europe & Member of Management Board
70
3 Mr. Theodor Niesmann
Chief Technical Officer & Member of Management Board
70
4 Mr. Stefan Schreiber
Executive Board Member for North America & Member of Management Board
70
5 Mr. Claus Sauter
Founder, Chairman of Management Board & Chief Executive Officer
70
6 Mr. Olaf Troeber
Chief Financial Officer & Member of Management Board
70
7 Ms. Alina Kohler
Head of Investor Relations
70

VERBIO Vereinigte BioEnergie AG Competitors